Area of research
Pulmonary and Respiratory Medicine · Statistics and Probability
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Statistical Methods in Clinical Trials, and Cancer-related cognitive impairment studies.
Value, Access, and High-Quality Medical Oncology Care: Can We Have It All?
Conflict of Interest: Moving From Disclosure to Avoidance.
Mapping Radiotherapy Resources for Prostate Cancer Trials in Nigeria: A STAMPEDE 2-Site Survey.
Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trials
Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 Inhibitor.
Adherence of published randomised Phase 3 cancer trials to principles proposed by common-sense oncology.
The Lancet Commission on prostate cancer: planning for the surge in cases
Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid review.
Pharmacological class effects of anticancer drugs: opportunities for decreasing healthcare spending.
Reply to D.J. Stewart et al.
Review of: "On the Need for Better Information from Randomized Clinical Trials in Oncology"
Common Sense Oncology: outcomes that matter
Progression-Free Survival Should Not Be Used as a Primary End Point for Registration of Anticancer Drugs.
Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer?
Priorities for cancer research in low- and middle-income countries: a global perspective
Cognitive impairment in adolescent and young adult cancer patients: Pre‐treatment findings of a longitudinal study
Management of Metastatic Hormone-Sensitive Prostate Cancer: Is Docetaxel Needed?
Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments
Dose Optimization of Sotorasib: Is the US Food and Drug Administration Sending a Message?
The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research
Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments.
Dose Optimization of Sotorasib: Is the US Food and Drug Administration Sending a Message?
Should Basket Trials Be Pathways to Drug Registration for Biomarker-Defined Subgroups of Advanced Cancers?
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy
A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer
Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?
Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study
Pretreatment Differences in Intraindividual Variability in Reaction Time between Women Diagnosed with Breast Cancer and Healthy Controls